MeSH tree: C01.610
For a vaccine to be effective, it must do two things. First, it must trigger an immune response. Second, the vaccine must train the body to remember the response so it can fight that same disease in the future. Now, new research ...
Jun 29, 2026
0
19
In a small study in the Democratic Republic of Congo, 6-week-old infants with healthy gut microbiomes were less likely to contract malaria in their first year of life. While the study is preliminary, it suggests the possibility ...
Jun 25, 2026
0
7
One-third of the world's population is infected with the Toxoplasma parasite, which can cause ocular toxoplasmosis, an eye infection that can damage the retina and result in permanent vision loss. Although often seen as an ...
Jun 25, 2026
0
8
Researchers from the University of Lincoln have contributed to an international study examining how interactions between people, free-roaming dogs and wildlife at urban tourist destinations may create opportunities for parasite ...
Jun 24, 2026
0
2
A parasitic worm might be the impetus behind a new generation of medicine. In a recent review in published in Clinical & Translational Immunology, Neima Briggs, MD, Ph.D., instructor of medicine (infectious diseases) at Yale ...
Jun 24, 2026
0
3
Researchers at the German Center for Infection Research (DZIF) have developed a promising single-dose malaria treatment that could help address growing drug resistance and simplify treatment for patients. The four-drug combination ...
Jun 23, 2026
0
3
Federal health officials are mobilizing against the New World screwworm, a flesh-eating parasite recently detected in animals in the southwest United States.
Jun 16, 2026
0
2
A major analysis of 25 studies across Africa and Asia finds that insecticide-treated nets cut malaria cases by up to 68%—but highlights challenges that threaten to undermine their long-term impact.
Jun 14, 2026
0
6
In a remote South African village, Paulina Mhlongo sits in the yard as health workers in green protective gear move briskly through her home, soaking the walls with anti-mosquito insecticide.
Jun 8, 2026
0
5
A phase 1 clinical trial testing the safety of a leishmaniasis vaccine is set to begin in the coming months—the first vaccine created to protect against the disfiguring skin disease common in tropical regions of the world ...
Jun 6, 2026
0
13
